BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32556562)

  • 41. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.
    Hiemenz MC; Kaur J; Kuang Z; Huang RSP; Harries L; Metzger D; Schiavone K; Millis SZ; Lin DI; Lechpammer M; Decker B; Mata DA; Reddy A; Parke M; Lee EY; Cui X; Iwenofu OH; Buehler D; Henderson L; Baldwin EM; Boikos SA; Ramkissoon SH; Smith SC
    Genes Chromosomes Cancer; 2023 Aug; 62(8):460-470. PubMed ID: 36862145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
    Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
    Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.
    Diaz-Perez JA; Nielsen GP; Antonescu C; Taylor MS; Lozano-Calderon SA; Rosenberg AE
    Hum Pathol; 2019 Aug; 90():45-53. PubMed ID: 31078563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
    Dehner CA; Rudzinski ER; Davis JL
    Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
    Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
    Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.
    Desmeules P; Joubert P; Zhang L; Al-Ahmadie HA; Fletcher CD; Vakiani E; Delair DF; Rekhtman N; Ladanyi M; Travis WD; Antonescu CR
    Am J Surg Pathol; 2017 Jul; 41(7):980-988. PubMed ID: 28505004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.
    Yoshida A; Wakai S; Ryo E; Miyata K; Miyazawa M; Yoshida KI; Motoi T; Ogawa C; Iwata S; Kobayashi E; Watanabe SI; Kawai A; Mori T
    Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.
    Gallagher KPD; van Heerden W; Said-Al-Naief N; Carlos R; Arboleda LPA; Rodrigues-Fernandes CI; Araújo ALD; Fonseca FP; Pontes HAR; Innocentini LMAR; Romañach MJ; Vargas PA; Lopes MA; Santos-Silva AR; Khurram SA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):354-366. PubMed ID: 35840496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype.
    Agaimy A; Stoehr R; Otto M; Bräsen JH; Pfarr N; Konukiewitz B; Kasajima A; Hartmann A; Klöppel G
    Virchows Arch; 2022 Feb; 480(2):481-486. PubMed ID: 34228212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors.
    Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Bräsen JH; Agaimy A; Klöppel G
    Virchows Arch; 2021 Dec; 479(6):1209-1219. PubMed ID: 34350470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
    Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
    J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
    Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR
    Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spindle Cell/Sclerosing Rhabdomyosarcoma With
    Rakheja D; Park JY; Alhasan M; Uddin N
    Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
    Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children.
    Zhang M; Yu Y; Guan X; Yao X; Jia C; Hong E; Guo Y; He L
    Pathol Res Pract; 2022 Feb; 230():153754. PubMed ID: 34990868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary sclerosing epithelioid fibrosarcoma of the spine: a single-institution experience.
    Righi A; Pacheco M; Pipola V; Gambarotti M; Benini S; Sbaraglia M; Frisoni T; Boriani S; Dei Tos AP; Gasbarrini A
    Histopathology; 2021 Jun; 78(7):976-986. PubMed ID: 33428796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
    Jo VY; Mariño-Enríquez A; Fletcher CD
    Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature.
    Cohen JN; Sabnis AJ; Krings G; Cho SJ; Horvai AE; Davis JL
    Hum Pathol; 2018 Nov; 81():281-290. PubMed ID: 29626598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.
    Brunac AC; Laprie A; Castex MP; Laurent C; Le Loarer F; Karanian M; Le Guellec S; Guillemot D; Pierron G; Gomez-Brouchet A
    Pediatr Blood Cancer; 2020 May; 67(5):e28185. PubMed ID: 31965718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.